LFCR (Lifecore Biomedical) Revenue: $90.75 Mil (TTM As of Mar. 2026)

Lifecore Biomedical  (NAS:LFCR) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Lifecore Biomedical Revenue Related Terms

The historical data trend for Lifecore Biomedical's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Revenue Chart

Lifecore Biomedical Annual Data
	Trend	May16	May17	May18	May19	May20	May21	May22	May23	May24	May25
Revenue		Get a 7-Day Free Trial					100.87	111.27	103.27	128.26	128.87

Lifecore Biomedical Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Sep25	Dec25	Mar26
Revenue	Get a 7-Day Free Trial															35.15	36.44	31.11	0.00	23.19

LFCR vs ANIK, DERM, ASRT: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifecore Biomedical Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Revenue distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Revenue falls into.

Lifecore Biomedical Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $90.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Business Description